These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29073262)

  • 1. Development and validation of immune dysfunction score to predict 28-day mortality of sepsis patients.
    Fang WF; Douglas IS; Chen YM; Lin CY; Kao HC; Fang YT; Huang CH; Chang YT; Huang KT; Wang YH; Wang CC; Lin MC
    PLoS One; 2017; 12(10):e0187088. PubMed ID: 29073262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care units.
    Fang WF; Chen YM; Lin CY; Huang KT; Kao HC; Fang YT; Huang CH; Chang YT; Wang YH; Wang CC; Lin MC
    PLoS One; 2017; 12(7):e0179749. PubMed ID: 28692671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospectively validated prediction of physiologic variables and organ failure in septic patients: The Systemic Mediator Associated Response Test (SMART).
    Slotman GJ
    Crit Care Med; 2002 May; 30(5):1035-45. PubMed ID: 12006800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
    Perry SE; Mostafa SM; Wenstone R; Shenkin A; McLaughlin PJ
    Intensive Care Med; 2003 Aug; 29(8):1245-52. PubMed ID: 12774155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.
    van Vught LA; Klein Klouwenberg PM; Spitoni C; Scicluna BP; Wiewel MA; Horn J; Schultz MJ; Nürnberg P; Bonten MJ; Cremer OL; van der Poll T;
    JAMA; 2016 Apr; 315(14):1469-79. PubMed ID: 26975785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological monitoring of sepsis using flow cytometry--quantitation of monocyte HLA-DR expression and granulocyte CD64 expression].
    Sedlácková L; Průcha M; Dostál M
    Epidemiol Mikrobiol Imunol; 2005 Apr; 54(2):54-61. PubMed ID: 16050543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
    Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
    Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients.
    Abe R; Hirasawa H; Oda S; Sadahiro T; Nakamura M; Watanabe E; Nakada TA; Hatano M; Tokuhisa T
    J Surg Res; 2008 Jun; 147(1):1-8. PubMed ID: 17720196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis.
    Hynninen M; Pettilä V; Takkunen O; Orko R; Jansson SE; Kuusela P; Renkonen R; Valtonen M
    Shock; 2003 Jul; 20(1):1-4. PubMed ID: 12813360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients.
    Ploder M; Pelinka L; Schmuckenschlager C; Wessner B; Ankersmit HJ; Fuerst W; Redl H; Roth E; Spittler A
    Shock; 2006 Feb; 25(2):129-34. PubMed ID: 16525350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity Scores in Emergency Department Patients With Presumed Infection: A Prospective Validation Study.
    Williams JM; Greenslade JH; Chu K; Brown AF; Lipman J
    Crit Care Med; 2016 Mar; 44(3):539-47. PubMed ID: 26901543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis.
    Andaluz-Ojeda D; Bobillo F; Iglesias V; Almansa R; Rico L; Gandía F; Resino S; Tamayo E; de Lejarazu RO; Bermejo-Martin JF
    Cytokine; 2012 Mar; 57(3):332-6. PubMed ID: 22197776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?
    Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A
    PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex cytokine profiling in patients with sepsis.
    Mera S; Tatulescu D; Cismaru C; Bondor C; Slavcovici A; Zanc V; Carstina D; Oltean M
    APMIS; 2011 Feb; 119(2):155-63. PubMed ID: 21208283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, risk factors, immune status and prognosis of secondary infection of sepsis: a retrospective observational study.
    Chen Y; Hu Y; Zhang J; Shen Y; Huang J; Yin J; Wang P; Fan Y; Wang J; Lu S; Yang Y; Yan L; Li K; Song Z; Tong C; Du S
    BMC Anesthesiol; 2019 Oct; 19(1):185. PubMed ID: 31627725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a model that uses enhanced administrative data to predict mortality in patients with sepsis.
    Lagu T; Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS; Higgins TL
    Crit Care Med; 2011 Nov; 39(11):2425-30. PubMed ID: 22005222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial to verify the value of the CD14(+) monocyte human leukocyte antigen DR as a marker in evaluating immunosuppression in patients with severe sepsis].
    Lin HY; Guo XS; Yao YM; Cheng WX; Weng ZH; Wei WT; Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Mar; 15(3):135-8. PubMed ID: 12831612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal chemiluminescent intensity in response to lipopolysaccharide assessed by endotoxin activity assay on admission day predicts mortality in patients with sepsis.
    Kiguchi T; Nakamori Y; Yamakawa K; Kitayama J; Wada D; Ogawa Y; Ogura H; Kuwagata Y; Shimazu T; Hamasaki T; Fujimi S
    Crit Care Med; 2013 Jun; 41(6):1443-9. PubMed ID: 23474675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.